# Effect of Evogliptin on Bone Metabolism in Human

> **NCT02587975** · PHASE4 · UNKNOWN · sponsor: **DongGuk University** · enrollment: 20 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2
- Osteoporosis

## Interventions

- **DRUG:** Evogliptin

## Key facts

- **NCT ID:** NCT02587975
- **Lead sponsor:** DongGuk University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-06
- **Primary completion:** 2016-11
- **Final completion:** 2017-03
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2016-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02587975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02587975, "Effect of Evogliptin on Bone Metabolism in Human". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02587975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*